

Cover Story
By Jordan Williams and Matthew Bin Han Ong
When the Senate Committee on Appropriations marked up the fiscal 2019 spending bill, NIH came out ahead—$2 billion ahead.
In Brief
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for June
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87
- Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer
- Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays - Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources - GLP-1 drugs linked to dramatically lower death rates in colon cancer patients















